1. Short title This Act may be cited as the Opioid Abuse Prevention and Treatment Act of 2017 . 2. Pilot project (a) In general The Secretary of Health and Human Services (referred to in this Act as the Secretary ) shall award grants to one or more States to carry out a 1-year pilot project to develop a standardized peer review process and methodology to review and evaluate prescribing and pharmacy dispensing patterns, through a review of prescription drug monitoring programs (referred to in this section as PDMP ) in the States receiving such grants. (b) Methodology The recipients of a grant under this section shall develop a systematic, standardized methodology to identify and investigate questionable or inappropriate prescribing and dispensing patterns of substances on schedule II or III under section 202 of the Controlled Substances Act ( 21 U.S.C. 812 ). Such peer review methodology and prescribing and dispensing patterns shall be shared with the appropriate State regulators and health profession boards. (c) Requirements A State receiving a grant under this section— (1) with respect to controlled substances for which a prescriber is required to be registered with by the Drug Enforcement Administration in order to prescribe such controlled substances, shall make the information with respect to such controlled substances from the PDMP available to State regulators and licensing boards